Skip to main content
Erschienen in: Rheumatology International 8/2006

01.06.2006 | Original article

Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients

verfasst von: A. Rajaee, A. Ebrahimi, A. Fotouhi Ghiam, T. Kalantari, A. Ghaderi

Erschienen in: Rheumatology International | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

Although, the cytotoxic T lymphocyte antigen-4 gene polymorphism at position 49 of exon-1 has been strongly elucidated in different autoimmune diseases, but its role in predisposition to systemic sclerosis (SSc) is yet controversial. This study intends to analyze the genetic correlation of the ctla-4 gene locus with diffuse systemic sclerosis (dSSc), as well as to understand the influence of these genotypes in disease expression. Seventy known cases of SSc, and 151 age-matched healthy controls, were participated in this investigation. The frequencies of AA, GG and AG genotypes were found to be 26 (37.1%), 5 (7.2%) and 39 (55.7%) in patients, and 60 (39.7%), 19 (12.6%) and 72 (47.7%) in controls, respectively. As indicated, the differences in genotype and allele frequencies between patients and controls were insignificant (P>0.05). Moreover, the distribution of CTLA-4 polymorphism between patients did not differ significantly according to clinical and serologic features. In Iranian patients, susceptibility to SSc is not influenced by a bi-allelic ctla-4 gene (A49G) polymorphism.
Literatur
1.
Zurück zum Zitat Zhou X, Tan FK, Wang N, Xiong M, Maghidman S, Reveille JD et al (2003) Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. Arthrit Rheum 48:2585–2592CrossRef Zhou X, Tan FK, Wang N, Xiong M, Maghidman S, Reveille JD et al (2003) Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. Arthrit Rheum 48:2585–2592CrossRef
2.
Zurück zum Zitat Derk CT, Jimenez SA (2003) Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2:181–191PubMedCrossRef Derk CT, Jimenez SA (2003) Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2:181–191PubMedCrossRef
3.
Zurück zum Zitat Bitterncourt PL, Palacios SA, Cancado ELR, Porta G, Carrilho FJ et al (2003) Cytotoxic T lymphocyte antigen-4 gene polymorphism do not confer susceptibility to Autoimmune Hepatitis type 1 and 2 In Brazil. Am J Gastroenterol 98:1616–1620 Bitterncourt PL, Palacios SA, Cancado ELR, Porta G, Carrilho FJ et al (2003) Cytotoxic T lymphocyte antigen-4 gene polymorphism do not confer susceptibility to Autoimmune Hepatitis type 1 and 2 In Brazil. Am J Gastroenterol 98:1616–1620
5.
Zurück zum Zitat Atamas, White SP, Barbara (2003) The role of chemokines in the pathogenesis of scleroderma. Cur Opin Rheumatol 15: 772–777CrossRef Atamas, White SP, Barbara (2003) The role of chemokines in the pathogenesis of scleroderma. Cur Opin Rheumatol 15: 772–777CrossRef
6.
Zurück zum Zitat Hasegawa M, Fujimoto M, Kikuchi K, Takehara K (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. Rheumatol 24:328–332 Hasegawa M, Fujimoto M, Kikuchi K, Takehara K (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. Rheumatol 24:328–332
7.
Zurück zum Zitat Takagi K, Kawaguchi Y, Hara M, Sugiura T, Harigai M, Kamatani N (2003) Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features. Clin Exp Immunol 134:538–544PubMedCrossRef Takagi K, Kawaguchi Y, Hara M, Sugiura T, Harigai M, Kamatani N (2003) Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features. Clin Exp Immunol 134:538–544PubMedCrossRef
8.
Zurück zum Zitat Neudecker BA, Stern R, Connolly MK (2004) Aberrant serum hyaluronan and hyaluronidase levels in scleroderma. Dermatol 150:469–476CrossRef Neudecker BA, Stern R, Connolly MK (2004) Aberrant serum hyaluronan and hyaluronidase levels in scleroderma. Dermatol 150:469–476CrossRef
9.
Zurück zum Zitat Kessel A, Rosner I, Rozenbaum M, Zisman D, Sagiv A, Shmuel Z et al (2004) Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappaB. J Clin Immunol 24:30–36PubMedCrossRef Kessel A, Rosner I, Rozenbaum M, Zisman D, Sagiv A, Shmuel Z et al (2004) Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappaB. J Clin Immunol 24:30–36PubMedCrossRef
10.
Zurück zum Zitat Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K (2004) Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts. Am J Pathol 164:1275–1292PubMed Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K (2004) Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts. Am J Pathol 164:1275–1292PubMed
11.
Zurück zum Zitat Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K (2004) Impaired Smad7-smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J Clin Invest 113:253–264PubMed Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K (2004) Impaired Smad7-smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J Clin Invest 113:253–264PubMed
12.
Zurück zum Zitat Chung L, Utz PJ (2004) Antibodies in scleroderma: direct pathogenicity and phenotypic association. Curr Rheumatol Rep 6:156–163PubMedCrossRef Chung L, Utz PJ (2004) Antibodies in scleroderma: direct pathogenicity and phenotypic association. Curr Rheumatol Rep 6:156–163PubMedCrossRef
13.
Zurück zum Zitat Tan FK (2004) Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 29:211–237CrossRef Tan FK (2004) Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 29:211–237CrossRef
14.
Zurück zum Zitat Tikly M, Rands A, McHugh N, Wordsworth P, Welsh K (2004) Human leukocyte antigen class II associations with systemic sclerosis in South Africans. Tissue Antigens 63:487–490PubMedCrossRef Tikly M, Rands A, McHugh N, Wordsworth P, Welsh K (2004) Human leukocyte antigen class II associations with systemic sclerosis in South Africans. Tissue Antigens 63:487–490PubMedCrossRef
15.
Zurück zum Zitat Chistiakov DA, Turakulov RI (2003) CTLA-4 and its role in autoimmune thyroid disease (Review). J Mol Endocrinol 31:21–36PubMedCrossRef Chistiakov DA, Turakulov RI (2003) CTLA-4 and its role in autoimmune thyroid disease (Review). J Mol Endocrinol 31:21–36PubMedCrossRef
16.
Zurück zum Zitat Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506–511PubMedCrossRef Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506–511PubMedCrossRef
17.
Zurück zum Zitat Steen VD, Medsger TA Jr (1990) Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am 16:1–10PubMed Steen VD, Medsger TA Jr (1990) Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am 16:1–10PubMed
18.
Zurück zum Zitat Kalantari T, Mostafavi H, Pezeshki AM, Farjadian S, Doroudchi M, Yeganeh F, Ghaderi A (2003) Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves’ disease. Autoimmunity 36:313–316PubMedCrossRef Kalantari T, Mostafavi H, Pezeshki AM, Farjadian S, Doroudchi M, Yeganeh F, Ghaderi A (2003) Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves’ disease. Autoimmunity 36:313–316PubMedCrossRef
19.
Zurück zum Zitat Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M et al (1997) Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto’s thyroiditis and Addison’s disease. J Clin Endocrinol 82:4130–4132CrossRef Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M et al (1997) Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto’s thyroiditis and Addison’s disease. J Clin Endocrinol 82:4130–4132CrossRef
20.
Zurück zum Zitat Gintrac M (1847) Note sur la sclerodermie. Rev Med Chir Paris 2:263–281 Gintrac M (1847) Note sur la sclerodermie. Rev Med Chir Paris 2:263–281
21.
Zurück zum Zitat Rodnan GP, Benedek TG (1962) A historical account of the study of progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med 57: 305–319PubMed Rodnan GP, Benedek TG (1962) A historical account of the study of progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med 57: 305–319PubMed
22.
Zurück zum Zitat Herrick AL, Worthington J (2002) Genetic epidemiology: systemic sclerosis. Arthritis Res 4:165–168PubMedCrossRef Herrick AL, Worthington J (2002) Genetic epidemiology: systemic sclerosis. Arthritis Res 4:165–168PubMedCrossRef
23.
Zurück zum Zitat Simmonds MJ, Gough SCL (2004) Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clin Experiment Immunol 136:1CrossRef Simmonds MJ, Gough SCL (2004) Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clin Experiment Immunol 136:1CrossRef
24.
Zurück zum Zitat Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 40 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J Immunol 165:6606–6611PubMed Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 40 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J Immunol 165:6606–6611PubMed
25.
Zurück zum Zitat Hudson LL, Silver RM, Pandey JP (2004) Ethnic differences in cytotoxic T lymphocyte associated antigen-4 genotype association with systemic sclerosis. Rheumatol 31:85–87 Hudson LL, Silver RM, Pandey JP (2004) Ethnic differences in cytotoxic T lymphocyte associated antigen-4 genotype association with systemic sclerosis. Rheumatol 31:85–87
26.
Zurück zum Zitat Takeuchi F, Kawasugi K, Nabeta H, Mori M, Tanimoto K (2002) Association of CTLA-4 with systemic sclerosis in Japanese patients. Clin Exp Rheumatol 20:823–828PubMed Takeuchi F, Kawasugi K, Nabeta H, Mori M, Tanimoto K (2002) Association of CTLA-4 with systemic sclerosis in Japanese patients. Clin Exp Rheumatol 20:823–828PubMed
27.
Zurück zum Zitat Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, Samsami DA (2004) Cytotoxic T lymphocyte antigen-4 in breast cancer. Breast Cancer Res Treat 86:1–7PubMedCrossRef Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, Samsami DA (2004) Cytotoxic T lymphocyte antigen-4 in breast cancer. Breast Cancer Res Treat 86:1–7PubMedCrossRef
28.
Zurück zum Zitat Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J (2001) CTLA-4 gene expression in influenced by promoter and exon 1 polymorphism. Genes Immun 2:145–152PubMedCrossRef Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J (2001) CTLA-4 gene expression in influenced by promoter and exon 1 polymorphism. Genes Immun 2:145–152PubMedCrossRef
29.
Zurück zum Zitat Hill CL, Nguyen AM, Roder D, Roberts-Thomson P (2003) Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 62:728–731PubMedCrossRef Hill CL, Nguyen AM, Roder D, Roberts-Thomson P (2003) Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 62:728–731PubMedCrossRef
30.
Zurück zum Zitat De Angelis R, Bugatti L, Cerioni A, Del Medico P, Filosa G (2003) Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer. Clin Rheumatol 22:49–52PubMedCrossRef De Angelis R, Bugatti L, Cerioni A, Del Medico P, Filosa G (2003) Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer. Clin Rheumatol 22:49–52PubMedCrossRef
31.
Zurück zum Zitat Bachleitner-Hofmann T, Machold K, Knobler R, Drach J, Grumbeck E, Gisslinger H (2002) Marked and sustained improvement of systemic sclerosis following polychemotherapy for coexistent multiple myeloma. Clin Exp Rheumatol 20:85–88PubMed Bachleitner-Hofmann T, Machold K, Knobler R, Drach J, Grumbeck E, Gisslinger H (2002) Marked and sustained improvement of systemic sclerosis following polychemotherapy for coexistent multiple myeloma. Clin Exp Rheumatol 20:85–88PubMed
Metadaten
Titel
Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients
verfasst von
A. Rajaee
A. Ebrahimi
A. Fotouhi Ghiam
T. Kalantari
A. Ghaderi
Publikationsdatum
01.06.2006
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 8/2006
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-005-0047-6

Weitere Artikel der Ausgabe 8/2006

Rheumatology International 8/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.